Unlocking Precision Medicine

(Paperback)

Publishing Details

Classifications

Physical Properties

Description

New medicines in the pipelinecanextend lives, save money, andeven help preventdisease before symptoms appear if we dont discourage their innovators and investors by trying to lower drug prices artificially. Unlocking Precision Medicineexploresthe environment necessary for creation of these health care game-changers, andexplainshow the marketplace can effectively make them more affordable to all without killing the golden goose.

Author Bio

Paul Howardis a senior fellow at the Manhattan Institute and director of health policy. Howard was part of the health care policy advisory group for Mitt Romneys 2012 presidential campaign, has testified twice before Congress, and serves on a panel of judges for Celgenes Innovation Impact Awards. He is a contributor to The Apothecary, the Forbes blog on health care policy and entitlement reform, and a regular columnist for The Morning Consult.

Peter Huberis a senior fellow at the Manhattan Institute, where he writes on drug development, energy, technology, and the law. His most recent full length book isThe Cure in the Code: How 20th Century Law Is Undermining 21st Century Medicine. Before joining MI, Huber was an associate professor at MIT. He clerked on the D.C. Circuit Court of Appeals for Ruth Bader Ginsburg and on the U.S. Supreme Court for Sandra Day OConnor.